Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$3.00 USD
-0.05 (-1.64%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.96 -0.04 (-1.33%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Bionano Genomics, Inc. has a market cap of $10.26M, which represents its share price of $3.05 multiplied by its outstanding shares number of 3.36M. As a small-cap company, BNGO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BNGO 3.00 -0.05(-1.64%)
Will BNGO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNGO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNGO
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now
BNGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
Other News for BNGO
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference | BNGO Stock News
Bionano Genomics (BNGO) Unveils Enhanced Genomic Analysis Software
Bionano Genomics announces release of latest versions of its VIA, Solve
Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, ...
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on ...